Alfacell Corporation - Pharmaceuticals & Healthcare

Alfacell Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Alfacell Corporation is a biopharmaceutical company engaged in developing drugs for the treatment of cancer and other pathological conditions. It is the first company to develop a biopharmaceutical product candidate that works similar to RNA interference (RNAi) through late-stage clinical trials. The major product candidate of the company is ONCONASE, an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. ONCONASE is currently going through the third phase of clinical trials for the treatment of different varieties of cancer.

Global Market Direct's Alfacell Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

• Provides key company information for business intelligence needs
• Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

• A quick ""one-stop-shop"" to understand the company.
• Support sales activities by understanding your customers' businesses.
• Qualify prospective partners and suppliers.
• Understand and respond to your competitors' business structure, strategy and prospects through.
• Understanding the key deals which have shaped the company.

Table Of Contents Table Of Contents 2 List of Tables 2 List of Figures 2 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Alfacell Corporation, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 6 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7 Alfacell Corporation, Pharmaceuticals & Healthcare, Deal Details 8 Equity Offering 8 Alfacell Completes Private Placement Of $11.3 Million 8 Alfacell Completes Private Placement Of $0.6 million 9 Alfacell Completes Private Placement Of $10 Million 10 Partnerships 11 Alfacell Signs An Agreement With Strativa 11 Key Competitors 12 Key Employees 12 Locations And Subsidiaries 12 Head Office 12 Appendix 13 Methodology 13 About Global Markets Direct 13 Contact Us 13 Disclaimer 13 List of Tables Alfacell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Alfacell Corporation, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Alfacell Corporation, Deals By Sector, 2004 to YTD 2009 6 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7 Alfacell Completes Private Placement Of $11.3 Million 8 Alfacell Completes Private Placement Of $0.6 million 9 Alfacell Completes Private Placement Of $10 Million 10 Alfacell Signs An Agreement With Strativa 11 Alfacell Corporation, Key Employees 12 List of Figures Alfacell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 4 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Alfacell Corporation, Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 6